©The Author(s) 2025.
World J Hepatol. Sep 27, 2025; 17(9): 110049
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.110049
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.110049
Table 5 Albumin-bilirubin score’s discriminatory power in comparison with other non-invasive tests for liver fibrosis
| ALBI | APRI score | AST to ALT | FIB-4 index | |
| AUC | 0.76 | 0.76 | 0.60 | 0.80 |
| P value | < 0.001 | < 0.001 | 0.005 | < 0.001 |
| Sensitivity (%) | 60 | 59 | 54 | 65 |
| Specificity (%) | 83 | 83 | 64 | 84 |
| 95%CI | 0.70-0.81 | 0.699-0.82 | 0.535-0.681 | 0.76-0.87 |
- Citation: Ewid M, Sherif H, Saquib N, Alammari AM, Ismail AAM, Alkahlot MH, Ahmed ZT, Al-Zabidi FZM, Al Mutiri N. Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals. World J Hepatol 2025; 17(9): 110049
- URL: https://www.wjgnet.com/1948-5182/full/v17/i9/110049.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i9.110049